Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerThe Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsPSA and beyond: alternative prostate cancer biomarkersHow Precisely Can Prostate Cancer Be Managed?Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.Reconsidering adjuvant versus salvage radiation therapy for prostate cancer in the genomics era.Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapyEvaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancerValidation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryA 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical ProstatectomyBiomarkers in prostate cancer: new era and prospective.Commercialized biomarkers: new horizons in prostate cancer diagnostics.Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality.Qualitative and Quantitative Requirements for Assessing Prognostic Markers in Prostate Cancer.Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy.Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.Prostate cancer radiomics and the promise of radiogenomics.Tissue-based biomarkers in prostate cancer.The Use of Biomarkers in Prostate Cancer Screening and Treatment.
P2860
Q26738703-13A4CB19-3740-4A39-982C-35667ACC233CQ26750672-FF5D354E-262A-4739-AC39-26847390F653Q26770646-E637B88B-1CEA-459F-AE14-CFE00A81D630Q28078942-1B4B6C68-D623-4A96-A3D6-1F25F4044B7AQ30009388-560A0D35-7E43-4FCD-9E16-3B61C5FE03B5Q30276626-9C98654E-936C-4ACC-ADF4-20D71C705AA0Q30371634-F1EFC3CA-62DF-4658-8591-79B04AA549FCQ30405851-80A5B1A8-85D7-4FCB-B3CE-6A6712395FCBQ30938412-4E551682-6017-4708-9D54-1CDA936539F3Q33898869-57A3FF4A-101B-45CB-B12D-D1971AE14788Q35211723-754A0E6B-3730-43D8-87DD-D9D665F8243EQ35868145-7455D15F-FCE5-44E8-A6E1-5053A894B87EQ38232466-56C4D048-66A7-43DA-91C6-A7D66E63A14CQ38364797-730574D3-A260-4856-9C6F-5225E8A7149DQ38767990-90DF62A6-2D3E-4885-8362-4049AA88AC88Q39417832-72394684-934A-479D-BE2C-C5B394C679D9Q41520709-F41943FC-B3C1-4868-8B80-6E797E9ACE91Q41540713-8168758C-2613-4E7E-9D0E-B446C9ABDF4EQ47135421-AEE7F83E-C873-4811-AAAD-9010B366CB5AQ47144748-A237E2F1-FDA5-4966-B01A-71BB9C6EAF43Q52689045-54675F91-36D0-4BA0-8080-8B02F7CF8777
P2860
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of a genomic classifier ...... t from the DECIDE study group.
@en
Impact of a genomic classifier ...... t from the DECIDE study group.
@nl
type
label
Impact of a genomic classifier ...... t from the DECIDE study group.
@en
Impact of a genomic classifier ...... t from the DECIDE study group.
@nl
prefLabel
Impact of a genomic classifier ...... t from the DECIDE study group.
@en
Impact of a genomic classifier ...... t from the DECIDE study group.
@nl
P2093
P2860
P356
P1433
P1476
Impact of a genomic classifier ...... t from the DECIDE study group.
@en
P2093
Anirban P Mitra
Christine Buerki
Darby J S Thompson
Jill Garrison
John Hornberger
Ketan Badani
Mercedeh Ghadessi
Penelope J Wood
P2860
P304
P356
10.18632/ONCOTARGET.918
P407
P577
2013-04-01T00:00:00Z